News

Company will provide services to manage data and terms of sales contracts

What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?

Regardless of how pending US legislation is resolved, manufacturers need to move ahead

Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations

Risk Evaluation & Mitigation Strategy (REMS) programs are evolving, with new complexities for compliance managers

Newly commercialized vaccine-production methods could moderate the feast-or-famine uncertainties of vaccine supply

Real business value arises from going beyond simple regulatory compliance for California's e-pedigree mandate

Why cloud-based software applications require a new training model

Better pharmacy stockroom efficiency, lower materials usage and patient convenience are benefits

Agency will begin accepting applications for participants in the expedited import-clearance process in mid-September

Medworth Acquisition Corp. gathers $63.5 million in an IPO to fund an acquisition

Effective programs need tailoring both to the specific drug and to patient needs, says Atlantis Healthcare

Company touts double-digit growth in 'niche' distribution

New study documents the effectiveness of in-pharmacy promotion as a DTC marketing channel

Company will provide services to manage data and terms of sales contracts

Container supplier opens a US branch office to accommodate business growth

The nonprofit industry R&D consortium addresses one of the difficulties of clinical trial administration

Stericycle's ExpertSolutions unit acquires a European marketing and recalls business

Cardinal Health's Retail Business Conference, ABC's ThoughtSpot and McKesson's IdeaShare meetings gather up independent pharmacist

NanoCool technology needs neither batteries nor dry ice/gel packs for 2-8C shipping

GAO advises Congress to clarify FDA authority; tells FDA to do better at documenting inspections and tracking compounding pharmacies

Outlook for successful Congressional action seems to hinge on what the House will do about compounding pharmacies

Evidence-based tactics--supported by the pharma industry--are a targeted goal

Dohmen will focus more closely on services to life sciences companies

ZS Associates report finds oncologists the most restrictive, with 65% placing moderate-to-severe limits

Lawsuit claims a violation of Sherman Antitrust Act

Cloud-based system will enable global pricing managers to analyze regulatory trends and simulate the effects of pricing changes

Survey of physicians, patients points to transdermal patches and nasal delivery as preferred methods, says Frost & Sullivan